文献速递主动脉疾病

动脉瘤性慢性主动脉夹层胸主动脉腔内修复术后主动脉重塑的临床结局与相关因素

Clinical Outcomes and Factors Associated With Aortic Shrinkage After Thoracic Endovascular Aortic Repair for Aneurysmal Chronic Aortic Dissection.
PubMed 文献 · J Endovasc Ther · 2023-10-26

该回顾性研究纳入2010年1月至2021年12月70例双腔型慢性主动脉夹层患者,评估胸主动脉腔内修复术(TEVAR)后临床结局及主动脉缩小预测因素。随访1年时64例(84%)完成CT复查,33例(52%)实现主动脉缩小。

要点

  • TEVAR治疗动脉瘤性慢性主动脉夹层早期主动脉相关死亡2例(3%),卒中和脊髓缺血各1例(2%)。
  • 5年免于主动脉相关死亡率和免于再干预率分别为96%和51%。
  • 夹层发病时长(每年OR 0.82)和主动脉弓/降主动脉最大径比值(每0.1 OR 1.34)是主动脉缩小的独立预测因素。

核心结论

  • TEVAR治疗动脉瘤性慢性主动脉夹层可获得满意的生存结局,但再干预率较高;夹层发病时长和术前主动脉形态可能影响术后主动脉缩小,较早干预可能带来更好的主动脉缩小。

研究设计与样本

  • 回顾性研究,纳入2010年1月至2021年12月70例双腔型慢性主动脉夹层患者,均行TEVAR覆盖胸主动脉主要内膜破口。

主要发现

  • 平均年龄63岁(IQR 54-68),男性54例(80%),夹层发病中位时长4年(IQR 1-10),最大主动脉直径53 mm(IQR 49-58)。
  • 57例(81%)需要行主动脉弓上分支去分支手术。
  • 早期主动脉相关死亡2例(3%),卒中和脊髓缺血各1例(2%)。
  • 5年免于主动脉相关死亡率和免于再干预率分别为96%和51%。
  • TEVAR后1年64例(84%)接受随访CT,其中33例(52%)实现主动脉缩小。

临床怎么用

  • 原文结论指出,较早干预可能带来更好的主动脉缩小。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The effectiveness of thoracic endovascular aortic repair (TEVAR) for chronic aortic dissection (AD) with aneurysmal degeneration remains controversial. We retrospectively investigated clinical outcomes and assessed predictors of aortic shrinkage after TEVAR for chronic aneurysmal AD. MATERIALS AND METHODS: Between January 2010 and December 2021, 70 patients with double-barrel-type chronic AD were enrolled. Major intimal tears in thoracic aorta were covered by stent graft. Early and late clinical outcomes, and diameter change of downstream aorta during follow-up period were reviewed. Subsequently, factors associated with aortic shrinkage were assessed by logistic regression analysis. RESULTS: Mean age was 63 (interquartile range [IQR]: 54-68) years, 54 (80%) men, median duration from AD onset was 4 (IQR: 1-10) years, and maximum aortic diameter was 53 (IQR: 49-58) mm. Supra-aortic debranching procedure was required in 57 (81%) patients. Early aorta-related death occurred in 2 (3%) patients. Both stroke and spinal cord ischemia occurred in 1 (2%) patient. Five-year freedom rates from aorta-related death and reintervention were 96% and 51%, respectively. Sixty-four patients underwent follow-up computed tomography (84%) 1 year after TEVAR, with 33 (52%) achieving aortic shrinkage. In multivariable analysis, duration from AD onset (per year) (odds ratio [OR]: 0.82, 0.70-0.97; p=0.017) and maximum aortic-diameter ratio between aortic arch and descending aorta (per 0.1) (morphologic index; OR: 1.34, 1.04-1.74; p=0.023) were independent aortic shrinkage predictors. CONCLUSIONS: Thoracic endovascular aortic repair for chronic AD with aneurysmal degeneration achieved satisfactory survival outcomes, but with a considerable reintervention rate. Duration from AD onset and preoperative aortic morphology could affect post-TEVAR aortic shrinkage. Earlier intervention could lead to better aortic shrinkage.Clinical ImpactThoracic endovascular aortic repair for chronic aortic dissection with aneurysmal degeneration showed low incidence of early and late aorta-related death. By contrast, aortic shrinkage rate was low with high incidence of reintervention to the residual downstream aorta. According to the assessment of preoperative variables, chronicity and aortic morphology could predict postoperative aortic shrinkage.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Shijo T, Shimamura K, Maeda K, et al. Clinical Outcomes and Factors Associated With Aortic Shrinkage After Thoracic Endovascular Aortic Repair for Aneurysmal Chronic Aortic Dissection. J Endovasc Ther. 2023. PMID: 37882164. doi:10.1177/15266028231206993

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。